Remove Data Remove Media Remove Safety
article thumbnail

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Cannabis Law Report

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

article thumbnail

FDA Issues Warning Letters to CBD Manufacturers Making “Over-The-Line” Health Claims

Canna Law Blog

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.”

CBD 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GemmaCert: Scientific Study Reveals Major Deviation Between Labelled and Actual CBD Potency in Commercial Products

Puff Puff Post

These results raise safety and efficacy concerns. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. Media Contact: Hadas Weizman hadas@marcomm.co.il +972(0)54-6077622. TEL AVIV, Israel , Feb.

CBD 96
article thumbnail

IRI Thought Leaders to Discuss New Trends and Research at Several Upcoming Industry Events

Cannabis Law Report

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHO: Jennifer Pelino, executive vice president, omnichannel media, IRI. . WHEN: Sept. 21, 2021, at 11:00 a.m.

Events 78
article thumbnail

Delta 8 Is Getting A Lot Of Attention – Not All Of It Is Good

Cannabis Law Report

If you feel like you’ve been catching a lot of Delta-8 THC content in the media lately, those aren’t just your social media apps hacking your brain. Hemp-derived Delta-8 THC is having a big moment in 2021 in terms of popularity and, most recently, in terms of concerns over legality, safety, and accuracy.

THC 90
article thumbnail

US Hemp Roundtable Analysis Of FDA CBD Report To Congress

Cannabis Law Report

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 71
article thumbnail

FDA Press Release: FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns

Cannabis Law Report

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 49